Curtiss-Wright
CW
$707.84
-1.09%
Curtiss-Wright Corp. is an engineered products and services provider serving commercial, defense, power generation, and industrial markets, with key offerings including pumps, valves, control systems, and weapons handling solutions. As a diversified industrial player with a strong foothold in naval and aerospace defense, the company benefits from long-term defense spending cycles and a reputation for mission-critical components. The current investor narrative centers on sustained revenue growth driven by naval and defense programs, margin expansion from operational efficiencies, and the stock's strong outperformance relative to the broader market, though valuation concerns and mixed analyst sentiment temper enthusiasm.…
CW
Curtiss-Wright
$707.84
Investment Opinion: Should I buy CW Today?
Rating: Hold. Curtiss-Wright is a high-quality industrial with strong fundamentals, but its elevated valuation limits upside potential. The consensus analyst rating is Buy with an average target of $798.17, implying 6.2% upside, which is modest given the risks.
Supporting Evidence: Revenue grew 13.4% YoY in Q1 2026, operating margin expanded to 17.6%, and ROE is a robust 19.1%. However, the trailing P/E of 42.6x is a 70% premium to the industry average of 25x, and the forward P/E of 43.9x suggests limited near-term earnings acceleration. The stock's 1-year return of +56.3% has already priced in much of the good news.
Risks & Conditions: The biggest risks are valuation compression and growth deceleration. If revenue growth falls below 10% or margins contract, the stock could re-rate lower. This Hold would upgrade to Buy if the P/E compresses below 30x or if the stock pulls back to $650 (approx. 37x P/E). It would downgrade to Sell if revenue growth drops below 5% or if the company issues negative guidance. Overall, CW is overvalued relative to its history and peers, but the premium may be justified by its superior profitability and defense exposure.
Sign up to view all
CW 12-Month Price Forecast
Curtiss-Wright is a fundamentally sound company with strong growth and margins, but its valuation is stretched. The base case of modest upside to $798 is most likely, given the premium multiple and limited near-term catalysts. The bull case requires an acceleration in defense spending, while the bear case could materialize if growth disappoints. The neutral stance reflects balanced risk/reward; an upgrade to bullish would require a pullback to a more attractive valuation or a clear catalyst for earnings acceleration.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Curtiss-Wright's 12-month outlook, with a consensus price target around $814.83 and implied upside of +15.1% versus the current price.
Average Target
$814.83
0 analysts
Implied Upside
+15.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$724 - $870
Analyst target range
Six analysts cover Curtiss-Wright, with a consensus recommendation of 'Buy' (mean rating 1.71 on a 1-5 scale). The average target price is $798.17, implying approximately 6.2% upside from the current price of $751.64. The distribution leans bullish, with no sell ratings, though several firms maintain Neutral/Hold positions. The target range spans from $724.00 (low) to $870.00 (high). The high target of $870 assumes continued margin expansion and defense spending growth, while the low target of $724 reflects concerns about valuation and potential cyclical headwinds. Recent ratings have been stable, with Citigroup and Stifel reiterating Neutral/Hold, while Morgan Stanley maintains an Overweight. The spread between low and high is 20.2%, indicating moderate uncertainty. Overall, the consensus is cautiously optimistic, with upside limited by the already elevated valuation.
Bulls vs Bears: CW Investment Factors
Curtiss-Wright presents a mixed picture: strong operational performance with accelerating revenue, expanding margins, and a solid balance sheet, but valuation is stretched at 42.6x trailing P/E, far above the industry average. The stock has outperformed dramatically over the past year, but near-term momentum is fading and analyst upside is limited. The key tension is whether the company can sustain its growth and margin trajectory to justify the premium valuation. Currently, the bear case has slightly stronger evidence due to valuation risk, but the bull case is supported by fundamental strength. The single most important factor is whether revenue growth can remain above 10% and margins continue to expand; if so, the premium may persist, but any deceleration could lead to multiple compression.
Bullish
- Strong Revenue Growth Acceleration: Q1 2026 revenue grew 13.4% YoY to $913.7M, accelerating from the prior year's pace. This growth is driven by defense programs (Naval Defense segment $250.1M, Aerospace Defense $179.4M) and industrial markets, providing diversified momentum.
- Expanding Profit Margins: Operating margin improved from 16.0% in Q1 2025 to 17.6% in Q1 2026, while net margin rose from 12.6% to 14.0%. This demonstrates operational leverage and cost control, enhancing earnings quality.
- Healthy Balance Sheet and Cash Flow: Debt-to-equity is a conservative 0.52, and TTM free cash flow is $590.8M. ROE of 19.1% indicates strong shareholder returns, and the current ratio of 1.44 provides liquidity cushion.
- Defensive Beta and Strong Momentum: Beta of 0.86 makes CW less volatile than the market, appealing for risk-averse investors. The stock has gained 56.3% over the past year, significantly outperforming the S&P 500's 20.9%.
Bearish
- Elevated Valuation Premium: Trailing P/E of 42.6x is a 70% premium to the Aerospace & Defense industry average of ~25x. This leaves little room for error; any earnings miss could trigger multiple compression.
- Limited Near-Term Upside to Targets: The average analyst target of $798.17 implies only 6.2% upside from the current price of $751.64. With the stock near its 52-week high of $808.16, the risk/reward is skewed to the downside.
- Short-Term Momentum Deceleration: The stock has declined 1.4% over the past month and underperformed the S&P 500 by 2.0% in that period. This could signal a consolidation or pullback after a strong run.
- Negative Free Cash Flow in Q1: Despite strong TTM FCF, Q1 2026 reported negative free cash flow of -$17.5M due to working capital build. This may raise concerns about cash conversion timing.
CW Technical Analysis
Curtiss-Wright is in a sustained uptrend, with a 1-year price change of +56.3%, significantly outpacing the S&P 500's +20.9%. The current price of $751.64 sits at 93% of its 52-week range ($463.00–$808.16), indicating the stock is near its highs and reflecting strong momentum, though caution is warranted as it approaches resistance. Over the past 3 months, the stock has gained 4.4%, while the 1-month change is -1.4%, showing a slight deceleration in short-term momentum. This divergence from the longer-term uptrend could signal a temporary pullback or consolidation phase, especially as the 1-month relative strength versus SPY is -2.0%, suggesting underperformance recently. The 52-week low of $463.00 provides a support level, while the 52-week high of $808.16 is a key resistance. A breakout above $808 could signal further upside, while a breakdown below $740 (recent lows) might indicate a deeper correction. With a beta of 0.86, the stock is less volatile than the market, offering a defensive profile within the industrials sector.
Beta
0.86
0.86x market volatility
Max Drawdown
-13.0%
Largest decline past year
52-Week Range
$463-$808
Price range past year
Annual Return
+46.2%
Cumulative gain past year
| Period | CW Return | S&P 500 |
|---|---|---|
| 1m | -8.9% | +0.3% |
| 3m | -3.8% | +4.7% |
| 6m | +6.6% | +7.5% |
| 1y | +46.2% | +18.4% |
| ytd | +23.7% | +9.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CW Fundamental Analysis
Revenue has been growing steadily, with Q1 2026 revenue of $913.7 million, up 13.4% year-over-year from $805.6 million in Q1 2025. The trailing twelve-month revenue trend shows acceleration, with Q4 2025 at $947.0 million and Q3 2025 at $869.2 million. Segment data reveals Naval Defense as the largest contributor at $250.1 million, followed by Aerospace Defense at $179.4 million and Power & Process at $167.1 million, indicating diversified growth drivers across defense and industrial end markets. The company is profitable, with Q1 2026 net income of $128.2 million and a net margin of 14.0%, up from 12.6% in Q1 2025. Gross margin improved to 36.3% from 36.2% a year ago, while operating margin expanded to 17.6% from 16.0%, reflecting operational leverage and cost controls. The balance sheet is healthy, with a debt-to-equity ratio of 0.52 and a current ratio of 1.44. Free cash flow for the trailing twelve months is $590.8 million, though Q1 2026 saw negative FCF of -$17.5 million due to working capital build. ROE stands at 19.1%, indicating strong returns on shareholder equity.
Quarterly Revenue
$913687000.0B
2026-03
Revenue YoY Growth
+13.4%
YoY Comparison
Gross Margin
36.3%
Latest Quarter
Free Cash Flow
$590761000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CW Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 42.6x, while the forward P/E is 43.9x, implying the market expects flat to slightly higher earnings growth. The gap is minimal, suggesting limited near-term earnings acceleration priced in. Compared to the Aerospace & Defense industry average P/E of approximately 25x (based on sector data), Curtiss-Wright trades at a 70% premium. This premium may be justified by its superior profitability (net margin of 14.0% vs. industry average ~8%) and consistent growth, but it also leaves little room for error. Historically, the stock's trailing P/E has ranged from 14.6x (Q4 2022) to 49.1x (Q1 2026). The current 42.6x is near the high end of its 5-year range, indicating that the market is pricing in optimistic expectations. A reversion to the mean would imply significant downside, but the premium could persist if growth and margins remain elevated.
PE
42.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 15x~49x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is valuation: at 42.6x trailing P/E, the stock is priced for perfection. Any earnings disappointment could lead to a sharp de-rating. Additionally, Q1 2026 saw negative free cash flow of -$17.5M, which, while likely temporary, highlights working capital volatility. The debt-to-equity ratio of 0.52 is manageable, but interest expense of $9.9M in Q1 is a modest drag. Revenue concentration in defense (Naval & Aerospace combined ~47% of Q1 revenue) exposes the company to government budget cycles, though current trends are favorable.
Market & Competitive Risks: The stock's beta of 0.86 provides some downside protection, but its premium valuation makes it vulnerable to sector rotation out of growth or defense stocks. The Aerospace & Defense industry average P/E of ~25x suggests that CW could face multiple compression if growth slows. Competitive risks include potential disruption from new entrants in defense electronics or industrial components, though CW's niche in mission-critical systems provides some moat. No recent news highlights specific threats, but the stock's 1-month underperformance versus SPY (-2.0%) may indicate waning investor enthusiasm.
Worst-Case Scenario: A combination of defense budget cuts, a broader market downturn, and an earnings miss could drive the stock down to its 52-week low of $463.00, representing a -38.4% decline from the current price of $751.64. This scenario would likely require a recession or significant geopolitical shift reducing defense spending. The analyst low target of $724.00 implies a more moderate -3.7% downside, but the 52-week low represents a realistic worst-case based on historical volatility.
FAQ
The key risks are: 1) Valuation risk: at 42.6x P/E, any earnings miss could trigger a sharp de-rating. 2) Growth deceleration: if revenue growth falls below 10%, the stock could lose its premium multiple. 3) Defense budget risk: CW's revenue is heavily tied to U.S. defense spending (Naval & Aerospace segments ~47% of Q1 revenue), which could be cut or delayed. 4) Market risk: with a beta of 0.86, the stock is less volatile than the market, but a broad downturn could still push it down. The most severe risk is a combination of defense cuts and a recession, which could drive the stock to its 52-week low of $463, a -38% decline.
The 12-month forecast is for modest upside, with the base case targeting $798 (analyst average), implying 6.2% gains. The bull case sees the stock reaching $870 (20% probability) if defense spending accelerates and earnings beat expectations. The bear case targets $724 or lower (25% probability) if growth slows or multiples contract. The most likely scenario is the base case, assuming continued steady growth and stable defense spending. However, the limited upside and high valuation suggest the stock may trade sideways in the near term.
CW is overvalued relative to its industry and its own history. The trailing P/E of 42.6x is a 70% premium to the Aerospace & Defense industry average of ~25x. Historically, the stock's P/E has ranged from 14.6x to 49.1x over the past 5 years, and the current level is near the high end. The market is pricing in optimistic expectations of sustained growth and margin expansion. While the premium may be justified by superior profitability (net margin 14.0% vs. industry ~8%), it leaves little margin of safety. A reversion to the mean would imply significant downside, but the premium could persist if growth continues.
CW is a high-quality company with strong fundamentals, but at 42.6x trailing P/E, it is priced for perfection. The analyst average target of $798.17 offers only 6.2% upside, which is modest given the risks. For long-term investors with a horizon of 3+ years, the stock could be a hold, but new buyers may want to wait for a pullback to a more reasonable valuation, such as below $700 (approx. 37x P/E). The biggest downside risk is multiple compression if growth slows. Overall, it is a good buy only for those willing to pay a premium for quality and hold through potential volatility.
CW is better suited for long-term investment due to its defensive beta (0.86), strong fundamentals, and exposure to secular defense spending. The stock has low volatility and pays a small dividend (yield 0.17%), making it a hold for income and growth. Short-term traders may find limited upside given the stock's proximity to its 52-week high and recent momentum deceleration. A minimum holding period of 3-5 years is recommended to ride out valuation cycles and benefit from earnings growth. The stock's 1-year return of +56.3% shows strong long-term potential, but near-term catalysts are lacking.